PT Kimia Farma Tbk

IDX-KAEF
Indonesia Stock Exchange
Healthcare Medical Distribution
Global Rank
#19305
Country Rank
#232
Market Cap
232.96 M
Price
0.0418
Change (%)
2.17%
Volume
3.9 M

PT Kimia Farma Tbk's latest marketcap:

232.96 M

As of 07/05/2025, PT Kimia Farma Tbk's market capitalization has reached $232.96 M. According to our data, PT Kimia Farma Tbk is the 19305th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 232.96 M
Revenue (ttm) 627.07 M
Net Income (ttm) -107,262,066.09
Shares Out 5.57 B
EPS (ttm) -0.02
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/14/2025
Market Cap Chart
Data Updated: 07/05/2025

PT Kimia Farma Tbk's yearly market capitalization.

PT Kimia Farma Tbk has seen its market value drop from Rp8.14 T to Rp232.96 M since 2014, representing a total decrease of 100.00% and an annual compound decline rate (CAGR) of 63.02%.
Date Market Cap Change (%) Global Rank
07/05/2025 Rp232.96 M 11.57% 19305
12/30/2024 Rp3.37 T -58.12% 18924
12/29/2023 Rp8.04 T 33.46% 12222
12/30/2022 Rp6.03 T -55.35% 14369
12/30/2021 Rp13.5 T -42.82% 9648
12/30/2020 Rp23.6 T 240% 5980
12/30/2019 Rp6.94 T -51.92% 10193
12/28/2018 Rp14.44 T -3.7% 6101
12/29/2017 Rp15 T -1.82% 6915
12/30/2016 Rp15.27 T 216.09% 6231

Company Profile

Company Overview

PT Kimia Farma Tbk is a leading pharmaceutical company in Indonesia, specializing in the manufacturing and sale of a diverse range of healthcare products. Established in 1817 and headquartered in Jakarta, the company has a strong presence both domestically and internationally.

Core Business Activities

  • Pharmaceutical Manufacturing: Produces generic, ethical, licensed, and narcotic medicines, as well as over-the-counter (OTC) drugs.
  • Raw Materials & Ingredients: Manufactures pharmaceutical raw materials, active pharmaceutical ingredients (APIs), and health supplements like effervescent tablets.
  • Diagnostic & Medical Devices: Supplies rapid test diagnostic tools and medical devices.
  • Consumer Products: Offers cosmetic products, health foods, quinine salt derivatives, castor oil, and edible oil.
  • Retail & Distribution: Operates a retail network for pharmaceutical products and ensures widespread distribution.

Global Reach

The company exports its products to multiple regions, including Asia, Europe, Australia, Africa, and the United States, reinforcing its position as a key player in the global pharmaceutical market.

Frequently Asked Questions

  • What is PT Kimia Farma Tbk's (IDX-KAEF) current market cap?
    As of 07/05/2025, PT Kimia Farma Tbk (including the parent company, if applicable) has an estimated market capitalization of $232.96 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • PT Kimia Farma Tbk global market capitalization ranking is approximately 19305 as of 07/05/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.